Simplex Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$575K Buy
28,271
+26,233
+1,287% +$534K ﹤0.01% 564
2025
Q1
$36K Buy
+2,038
New +$36K ﹤0.01% 1404
2024
Q4
Hold
0
2667
2024
Q3
Sell
-8,600
Closed -$318K 2515
2024
Q2
$318K Sell
8,600
-15,501
-64% -$573K ﹤0.01% 774
2024
Q1
$1.01M Buy
+24,101
New +$1.01M ﹤0.01% 453
2023
Q4
Hold
0
2631
2023
Q3
Sell
-491
Closed -$16K 2514
2023
Q2
$16K Buy
+491
New +$16K ﹤0.01% 1602
2023
Q1
Sell
-12,102
Closed -$539K 2556
2022
Q4
$539K Buy
12,102
+3,186
+36% +$142K ﹤0.01% 476
2022
Q3
$250K Sell
8,916
-7,630
-46% -$214K ﹤0.01% 817
2022
Q2
$446K Buy
16,546
+4,294
+35% +$116K ﹤0.01% 588
2022
Q1
$417K Sell
12,252
-738
-6% -$25.1K ﹤0.01% 801
2021
Q4
$501K Sell
12,990
-23,921
-65% -$923K ﹤0.01% 772
2021
Q3
$1.27M Sell
36,911
-200
-0.5% -$6.88K ﹤0.01% 453
2021
Q2
$1.24M Buy
37,111
+34,565
+1,358% +$1.15M ﹤0.01% 456
2021
Q1
$52K Sell
2,546
-25,598
-91% -$523K ﹤0.01% 1687
2020
Q4
$493K Buy
28,144
+11,082
+65% +$194K ﹤0.01% 656
2020
Q3
$253K Sell
17,062
-45,530
-73% -$675K ﹤0.01% 757
2020
Q2
$813K Buy
+62,592
New +$813K ﹤0.01% 328
2020
Q1
Sell
-13,705
Closed -$30K 2207
2019
Q4
$30K Buy
13,705
+9,522
+228% +$20.8K ﹤0.01% 1377
2019
Q3
$8K Sell
4,183
-1,582
-27% -$3.03K ﹤0.01% 1513
2019
Q2
$15K Buy
5,765
+4,937
+596% +$12.8K ﹤0.01% 1359
2019
Q1
$4K Buy
+828
New +$4K ﹤0.01% 1559
2018
Q4
Hold
0
2033
2018
Q3
Hold
0
2172
2018
Q2
Hold
0
2183
2018
Q1
Sell
-122
Closed -$5K 2102
2017
Q4
$5K Buy
+122
New +$5K ﹤0.01% 1679
2017
Q3
Sell
-961
Closed -$35K 1909
2017
Q2
$35K Buy
+961
New +$35K ﹤0.01% 1196
2017
Q1
Hold
0
1976
2016
Q4
Hold
0
1864
2016
Q3
Hold
0
1787
2016
Q2
Sell
-885
Closed -$50K 1851
2016
Q1
$50K Buy
885
+602
+213% +$34K ﹤0.01% 843
2015
Q4
$66K Sell
283
-29
-9% -$6.76K 0.01% 827
2015
Q3
$49K Buy
312
+26
+9% +$4.08K ﹤0.01% 943
2015
Q2
$108K Sell
286
-1,133
-80% -$428K 0.01% 657
2015
Q1
$593K Buy
1,419
+668
+89% +$279K 0.07% 153
2014
Q4
$206K Buy
+751
New +$206K 0.03% 311